NCT02754349View on ClinicalTrials.gov

Validation Study of Pulse Wave Velocity and Augmentation Index in Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Atrial Fibrillation
Interventions
DEVICE

SphygmoCor version 7, AtCor Medical, Sydney, Australia

Pulse wave velocity, augmentation index and central blood pressure measurement with applanation tonometry before and after electrical cardioversion

Trial Locations (1)

9300

OLV Hospital, Aalst

All Listed Sponsors
lead

Onze Lieve Vrouw Hospital

OTHER

NCT02754349 - Validation Study of Pulse Wave Velocity and Augmentation Index in Atrial Fibrillation | Biotech Hunter | Biotech Hunter